Hubert Tseng
Senior Translational Scientist Officer
Clinical Sciences
Targazyme
Switzerland
Biography
Dr. Tseng, Ph.D., is the Senior Translational Scientist at Targazyme, where his role is to identify new applications for Targazyme’s groundbreaking clinical candidates in fucosylation in oncology and immunotherapy and raise funds to advance these projects into clinical trials. Prior to joining Targazyme, Dr. Tseng was the Senior Scientist, R&D at Nano3D Biosciences, where he similarly developed novel applications for its 3D cell culture in in vitro assay development and regenerative medicine. Dr. Tseng earned a Ph.D. in Bioengineering from Rice University, and a B.S. in Engineering Mechanics and Applied Mathematics & Statistics from Johns Hopkins University.
Research Interest
oncology and immunotherapy
